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Background: The Pediatric Quality of Life InventoryTM (PedsQLTM) is a widely used instrument to measure pediatric
health-related quality of life (HRQOL) in children aged 2 to 18 years. The current study aimed to evaluate the
reliability and validity of the Chinese version of the PedsQLTM 3.0 Neuromuscular Module in children with
Duchenne muscular dystrophy (DMD).
Methods: The PedsQLTM 3.0 Neuromuscular Module was translated into Chinese following PedsQLTM Measurement
Model Translation Methodology. The Chinese version scale was administered to 56 children with DMD and their
parents, and the psychometric properties were evaluated.
Results: The missing value percentages for each item of the Chinese version scale ranged from 0.00% to 0.54%.
Internal consistency reliability approached or exceeded the minimum reliability standard of α = 0.7 (child α = 0.81,
parent α = 0.86). Test-retest reliability was satisfactory, with intraclass correlation coefficients (ICCs) of 0.66 for
children and 0.88 for parents (P < 0.01). Correlation coefficients between iteims and their hypothesized subscales
were higher than those with other subscales (P < 0.05). The subscale of “About My/My Child’s Neuromuscular
Disease” significantly related to mobility and stair climbing status (Child t = 2.21, Parent t = 2.83, P < 0.05). The inter-
correlations among the Chinese version of the PedsQLTM 3.0 Neuromuscular Module and the PedsQLTM 4.0 Generic
Core Scales had medium to large effect sizes (P < 0.05). The child self-report scores were in moderate agreement
with the parent proxy-report scores (ICC = 0.51, P < 0.05).
Conclusions: The Chinese version of the PedsQLTM 3.0 Neuromuscular Module has acceptable psychometric
properties. It is a reliable measure of disease-specific HRQOL in Chinese children with DMD.
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Duchenne muscular dystrophy (DMD) is the most com-
mon form of muscular dystrophy in childhood and affects
1:3500 live male births [1]. DMD is caused by mutations
(typically deletions) in the dystrophin gene on the X
chromosome [2]. Since the gene was cloned in 1986, many
strategies for treatment have been proposed and tested in
animal models, as well as human subjects [3]. Although
there are no specific DMD treatments, corticosteroid, nu-
trition, respiratory, cardiac, orthopedic, rehabilitative, and
psychosocial interventions have improved function, quality
of life, health, and longevity. Thus, children diagnosed with
DMD may be able to reach the fourth decade of life, which
is a significant improvement over the historical DMD life
expectancy [4-8].
Health-related quality of life (HRQOL) is increasingly ac-
knowledged as an important health outcome measure in
clinical trials and health services research and evaluation in-
volving children with neuromuscular disorders [9-12].
However, one challenge in measuring pediatric HRQOL is
that the instrument must account for physical, emotional,
social, and cognitive development that takes place during
childhood and adolescence. In addition, questionnaires
should provide the required information [13]. There is an
emerging perspective that both generic and disease-specific
HRQOL measures should be administered to pediatric pa-
tients with chronic health conditions in order to compre-
hensively evaluate patient HRQOL [14,15].
The Pediatric Quality of Life Inventory (PedsQLTM)
Measurement Model was designed to integrate the relative
merits of a generic core instrument with disease-specific
modules [11,12,16-19]. The PedsQLTM Measurement
Model was designed to develop and test brief measures for
the broadest age group empirically feasible, including child
self-report for young children [20,21]. The PedsQLTM 4.0
Generic Core Scales was specifically intended for applica-
tion in healthy and patient populations [22]. It has been
translated into many languages and widely used in more
than 60 countries [23]. The Chinese version of the
PedsQLTM 4.0 Generic Core Scales has been developed and
psychometrically evaluated [24], but the Chinese version
PedsQLTM 3.0 Neuromuscular Module for measuring
HRQOL dimensions in children ages 2 to 18 years with
neuromuscular disorders [10-12] has not been assessed for
reliability and validity. The aim of the current study was to
investigate the psychometric properties of the Chinese ver-
sion of the PedsQLTM 3.0 Neuromuscular Module in chil-
dren with DMD for use in conjunction with the Chinese
version of the PedsQLTM 4.0 Generic Core Scales.
Methods
Subjects
This study was carried out in China between December
2009 and December 2011. Children aged 2 to 18 yearswith DMD and their parents were recruited through the
Children’s Hospital, Chongqing Medical University. The
diagnosis of DMD was initially based on their clinical
history and neuromuscular findings and was confirmed
by DNA testing or muscular biopsy. Children were ex-
cluded from this study if they had other chronic diseases
or major developmental disorders. Families who did not
agree to participate were also excluded. A total of 56
families were included, and informed consent forms
were signed by all subjects and their parents. It was ap-
proved in compliance with the Helsinki Declaration by
the Ethics Committee of Children's Hospital, Chongqing
Medical University. The average age of the 56 male
DMD patients was 7.54 (standard deviation [SD] = 4.06;
range 2–13 years. Six were ages 2–4, 18 were ages 5–7,
and 32 were ages 8–13. The sample was classified into
two grades using the Vignos scale for lower extremities
[25]. Thirty-seven (66.07%) children could climb stairs,
but 19 could not.
Measures
PedsQLTM 3.0 neuromuscular module
The module encompasses three scales: 1) About My/My
Child’s Neuromuscular Disease (17 items), 2) Communi-
cation (3 items), and 3) About Our Family Resources (5
items) [11,12]. The scale is comprised of parallel child
self-report and parent proxy-report formats for children
aged 5 to 18 years, and a parent proxy-report format for
children ages 2 to 4 years. It is divided into seven forms,
including child self-report formats for ages 5–7, 8–12,
and 13–18 and parent proxy-report formats for ages 2–
4, 5–7, 8–12, and 13–18. The young child form (ages 5–
7 years) does not contain the “Communication” or
“About Our Family Resources” Scale. Items in all forms
are essentially identical but contain slightly different lan-
guage for first or third person tense. The participants
are asked how much of a problem each item had been
during the past month. Responses are rated on a 5-point
Likert scale across child self-report for children, teens,
and parent proxy-reports (0 = never a problem, 1 = al-
most never a problem, 2 = sometimes a problem, 3 =
often a problem, 4 = almost always a problem). Items are
linearly transformed to a 0 to 100 scale (0 = 100, 1 = 75,
2 = 50, 3 = 25, and 4 = 0) so that higher scores indicate
better HRQOL. Scale scores are computed as the sum of
the items divided by the number of items answered. If
more than 50% of the items in the scale are missing, the
scale score is not computed [26].
PedsQLTM 4.0 generic core scales
The 23-item PedsQLTM 4.0 Generic Core Scales encom-
pass: 1) Physical Functioning (8 items), 2) Emotional
Functioning (5 items), 3) Social Functioning (5 items),
and 4) School Functioning (5 items) [20,22,24]. The
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are the same as those of the PedsQLTM 3.0 Neuromus-
cular Module. To create the Psychosocial Health Sum-
mary Score, the mean is computed as the sum of the
items divided by the number of items answered in the
Emotional, Social, and School Functioning Subscales.
Procedure
The PedsQLTM Measurement Model Translation Metho-
dology was strictly followed in the linguistic translation
process of the PedsQLTM 3.0 Neuromuscular Module in
this study [27]. It is summarized as the procedure of
Forward Translation - Backward Translation – Prelimin-
ary Test - Field Test. The instruments were independently
translated into Chinese by a pediatrician and a medical
English teacher, both of whom were fluent in English, and
a multidisciplinary team reviewed both drafts. A single
reconciled Chinese version was developed after discussion.
It was translated back into English by a bilingual
pediatrician. Then, a comparison between the versions
was made to detect any misunderstandings or mistransla-
tions, and a second Chinese version was written [24]. Cog-
nitive debriefing was conducted with six children with
DMD and their parents to confirm that the final Chinese
version was understandable and acceptable. Reports
for all stages were sent to and accepted by Mapi Re-
search Institute in Lyon, France, on behalf of Dr.
James W. Varni, the copyright owner of the PedsQLTM.
Data collection
Three physicians were trained as interviewers before the
formal start of investigation. Participants completed the
Chinese version of the PedsQLTM 3.0 Neuromuscular
Module and the PedsQLTM 4.0 Generic Core Scales
separately during hospitalization or an outpatient de-
partment visit. Paper-and-pencil questionnaires wereTable 1 Reliability and descriptive statistics of the Chinese ve
Scale n α
Child self-report
Total scale 32 0.81
About My Neuromuscular Disease 50 0.87
Communication 32 0.80
About Our Family Resources 32 0.73
Parent proxy-report
Total scale 56 0.86
About My Child’s Neuromuscular Disease 56 0.87
Communication 56 0.83
About Our Family Resources 56 0.85
Note: Higher values denote better HRQOL.
% Floor/% Ceiling, the percentage of scores at the extremes of the scaling range; αself-administered for parents and for children ages 8 to
18 years and interview-administered for children ages 5–
7 years. The interviewers were available to assist if the
parents/children had questions on semantic or concep-
tual understanding. In the 56 parent questionnaires, 43
were completed by both parents together at the same
time, and 13 by a single parent only. For test-retest reli-
ability, a subset of (n =30) completed the PedsQLTM
measures a second time 4–6 weeks later during a rou-
tinely scheduled clinic visit if they had suffered no ad-
verse events since the first visit.
Data analysis
Data were analyzed with SPSS 17.0 for Windows.
Descriptive analysis was used to report the demographic
characteristics of children with DMD. The presence of
floor and ceiling effects, which was the percentage of
scores at the extremes and provided information on the
distribution in a scale, was assessed for the Chinese ver-
sion of the PedsQLTM 3.0 Neuromuscular Module. Con-
tinuous variables are presented as mean and standard
deviation (mean ± SD). Categorical variables are shown
as observed frequencies and proportions. Feasibility was
determined from the percentage of missing values [28].
Scale internal consistency reliability for the Chinese ver-
sion scale was determined at baseline by calculating
Cronbach’s alpha coefficient [29]. Scales with reliabilities
≥0.70 are recommended for comparing patient groups,
while a reliability criterion of 0.90 is recommended for
analyzing individual patient scores [30,31].
Test-retest reliability for the Chinese version scale was
assessed for a subset of the sample (n = 30) using
intraclass correlation coefficients (ICCs) [32,33]. Patients
and their parents were assessed an average of 35.82 days
(SD = 10.36) after baseline. ICCs ≤0.40 were designatedrsion of the PedsQLTM 3.0 neuromuscular module for DMD
Mean SD % floor % ceiling
53.64 10.55 2.7 19.5
71.24 12.06 1.3 24.7
39.06 22.54 16.7 1.9
52.50 15.76 1.7 3.8
52.88 9.34 2.9 16.2
71.06 11.23 1.2 22.5
37.50 20.41 14.6 2.1
50.09 15.06 1.6 3.3
, Cronbach’s alpha coefficient; SD, standard deviation.
Table 2 ICCs for test-retest reliability of the Chinese
















Note: *P < 0.05, ΔP < 0.01.
ICC, intraclass correlation designated as ≤ 0.40 poor to fair agreement; 0.41-
0.60 moderate agreement; 0.61-0.80 good agreement; and 0.81-1.00
excellent agreement.
Table 3 Item-subscale correlations of the Chinese version of t
Subscales & Items Chil
AN
About My/My Child’s Neuromuscular Disease (AN)
It is hard to breathe 0.05
Get sick easily 0.05
Get sores and/or rashes 0.29
Legs hurt 0.73
Feel tired 0.80
Back feel stiff 0.59
Wake up tired 0.74
Hands are weak 0.63
Hard to use the bathroom 0.71
Hard to gain or lose weight when one wants to 0.65
Hard to use my hands 0.69
Hard to swallow food 0.11
Takes a long time to bathe or shower 0.70
Get hurt accidentally 0.59
Take a long time to eat 0.48
Hard to turn oneself during the night 0.70
Hard to go places with one’s equipment 0.66
Communication (C)
Hard to tell the doctors and nurses how I feel 0.28
Hard to ask the doctors and nurses questions 0.09
Hard to explain the illness to other people 0.13
About Our Family Resources (FR)
Hard for my family to plan activities like vacations 0.13
Hard for my family to get enough rest 0.12
I think money is a problem in our family 0.03
I think my family has a lot of problems 0.01
Do not have the equipment one needs 0.05
Note: Pearson’s product moment correlations are designated as small (0.10), mediu
Underlined values represent correlations between items and their hypothesized sub
AN, About My Neuromuscular Disease; C, Communication; FR, About Our Family Re
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ment, 0.61-0.80 good agreement, and 0.81-1.00 excellent
agreement [32-34].
Multitrait scaling analysis for the Chinese version
scale was conducted at baseline using Pearson correl-
ation analysis to determine the item-subscale correla-
tions. Good scaling success was indicated if the
correlation between an item and its hypothesized
subscale was stronger than those with other subscales
[35].
Construct validity for the Chinese version scale was
determined utilizing the known-groups method [33],
which compares scale scores across groups known to
differ in the health construct being investigated. Because
of the small number of patients in one category, we usedhe PedsQLTM 3.0 neuromuscular module for DMD
d self-report Parent proxy-report
C FR AN C FR
0.02 0.05 0.12 0.17 0.04
0.18 0.22 0.09 0.14 0.21
0.17 0.03 0.27 0.19 0.10
0.37 0.15 0.78 0.30 0.65
0.14 0.21 0.77 0.12 0.51
0.16 0.01 0.63 0.29 0.43
0.04 0.00 0.71 0.16 0.56
0.28 0.13 0.62 0.15 0.54
0.43 0.31 0.69 0.36 0.30
0.10 0.13 0.68 0.25 0.57
0.31 0.03 0.78 0.07 0.56
0.20 0.15 0.01 0.46 0.04
0.00 0.07 0.71 0.25 0.56
0.20 0.01 0.59 0.08 0.29
0.14 0.19 0.48 0.21 0.28
0.08 0.03 0.69 0.39 0.47
0.22 0.36 0.61 0.46 0.37
0.81 0.19 0.26 0.83 0.18
0.87 0.28 0.35 0.89 0.12
0.87 0.16 0.21 0.87 0.02
0.18 0.53 0.55 0.17 0.69
0.23 0.76 0.54 0.04 0.80
0.19 0.82 0.46 0.10 0.87
0.17 0.84 0.64 0.06 0.79
0.14 0.70 0.52 0.09 0.80
m (0.30), and large (0.50).
scales.
sources.
Table 4 The known-groups method test comparing stair climbing status of the Chinese version of the PedsQLTM 3.0
neuromuscular module for DMD
Scale Can climb stairs Cannot climb stairs Independent sample t-test
n Mean (SD) n Mean (SD) t P
Child self-report
Total score 13 57.58 (11.24) 19 50.42 (8.20) 2.07 0.05
About My Neuromuscular Disease 31 75.49 (11.85) 19 68.15 (11.44) 2.21 0.03
Communication 13 43.33 (22.97) 19 35.29 (22.15) 1.01 0.32
About Our Family Resources 13 54.00 (12.98) 19 51.18 (18.16) 0.5 0.62
Parent proxy-report
Total score 37 55.66 (7.89) 19 48.26 (12.10) 2.50 0.02
About My Child’s Neuromuscular Disease 37 74.16 (10.34) 19 65.90 (10.97) 2.83 0.01
Communication 37 40.24 (19.85) 19 32.94 (21.00) 1.30 0.20
About Our Family Resources 37 52.57 (11.72) 19 45.95 (19.01) 1.62 0.11
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climb stairs (yes vs. no) with the baseline Neuromuscu-
lar Module scores to perform the construct validity.
Based on previous findings regarding the association
with patient HRQOL, we hypothesized that the “About
My/My Child’s Neuromuscular Disease” subscale would
be correlated to stair climbing status, with higher QOL
higher for patients who could climb stairs compared
with those who could not [11,12].
Additional construct validity was examined through an
analysis of intercorrelations among Neuromuscular Mo-
dule Scores, Generic Core Scales, and Summary Scores
[30]. We hypothesized greater disease-specific symptoms
or problems would correlate with lower overall generic
HRQOL based on the conceptualization of disease-Table 5 Pearson’s product moment correlations among the C
Scale TG PH P
PedsQLTM Generic Core Scales
Total Generic Core (TG) — 0.43 0
Physical Health (PH) 0.47 — 0
Psychosocial Health (PsyH) 0.61 0.49 —
Emotional Functioning (EF) 0.41 0.33 0
Social Functioning (SF) 0.78 0.56 0
School Functioning (SchF) 0.67 0.46 0
PedsQLTM Neuromuscular Module
Total Neuromuscular Module (TN) 0.60 0.52 0
About My/My Child’s Neuromuscular Disease (AN) 0.39 0.38 0
Communication (C) 0.39 0.66 0
About Our Family Resources (FR) 0.11 0.01 0
Note: Pearson’s product moment correlations for child self-report and parent proxy
Pearson’s product moment correlations are designated as small (0.10), medium (0.3
Underlined values represent correlations between child self-report and parent prox
TG, Total Generic Core; PH, Physical Health; PsyH, Psychosocial Health; EF, Emotiona
Neuromuscular Module; AN, About My Neuromuscular Disease; C, Communication;specific symptoms as causal indicators of generic
HRQOL [36]. Pearson Product Moment Correlation co-
efficients are designated as small (0.10-0.29), medium
(0.30-0.49), and large (≥0.50) [37].
Agreement between child self-reports and parent
proxy-reports of the Chinese version scale was deter-
mined through ICCs [38], which offers an index of abso-
lute agreement because it takes into account the ratio
between subject variability and total variability [38,39].
Results
Descriptive analysis
A total of 50 children and 56 parents completed the
Chinese version of the PedsQLTM 3.0 Neuromuscular
Module questionnaire, and the average time was abouthinese version of the PedsQLTM Scales for DMD
syH EF SF SchF TN AN C FR
.56 0.60 0.67 0.74 0.67 0.14 0.61 0.28
.55 0.44 0.43 0.50 0.43 0.28 0.22 0.25
0.50 0.72 0.61 0.28 0.14 0.55 0.45
.31 — 0.48 0.38 0.48 0.10 0.50 0.12
.40 0.65 — 0.26 0.40 0.15 0.68 0.51
.60 0.61 0.66 — 0.24 0.22 0.49 0.37
.50 0.55 0.58 0.57 — 0.25 0.44 0.25
.23 0.46 0.30 0.40 0.30 — 0.20 0.27
.41 0.27 0.45 0.36 0.45 0.27 — 0.01
.21 0.04 0.18 0.34 0.18 0.10 0.20 —
-report are presented above and below the diagonal dashed lines, respectively.
0), and large (0.50).
y-report subscales.
l Functioning; SF, Social Functioning; SchF, School Functioning; TN, Total
FR, About Our Family Resources.
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tions, and floor and ceiling effects for each subscale
score. Ceiling effects in both child self- and parent
proxy-reports ranged from 1.9-24.7%, with highest
values in the “About My/My Child’s Neuromuscular Dis-
ease” subscale. Floor effects ranged from 1.2-14.6%, with
a notably high value for the “Communication” subscale.
Feasibility
The percentage of missing item responses for all scales
was 0.54% and 0.31% for the child self-report and parent
proxy-reports, respectively.
Internal consistency reliability
Internal consistency reliability coefficients are presented
in Table 1. All child self-report and parent proxy-report
scales exceeded the minimum reliability standard of 0.70
required for group comparisons.
Test-retest reliability
ICCs for test-retest reliability of the Chinese version
scale are presented in Table 2. The majority of these
ICCs had good to excellent reliability.
Item-subscale correlations
Pearson correlation coefficients between items and
subscale scores are presented in Table 3. We found that
most items had moderate to strong correlations with
their hypothesized subscales, which were higher than
those with other subscales (P < 0.05).
Construct validity
Construct validity was assessed by comparing stair
climbing mobility groups (climb stairs and non-climb)
and is presented in Table 4. The a priori hypothesis that
“About My/My Child’s Neuromuscular Disease” subscale
would be significantly related to mobility was confirmed
for both child self-report and parent proxy-report. The
means increased for children who could climb stairs and
those who could not for all of the Chinese version
subscale scores. The inter-correlations between theTable 6 ICCs of the Chinese version of the PedsQLTM 3.0




About My/My Child’s Neuromuscular Disease 0.49Δ
Communication 0.21
About Our Family Resources 0.49*
Note: *P < 0.05, ΔP < 0.01.
ICC = intraclass correlation, ICCs are designated as ≤ 0.40 poor to fair
agreement, 0.41-0.60 moderate agreement, 0.61-0.80 good agreement, and
0.81-1.00 excellent agreement.Generic Core Scales and Summary Scores with the
Neuromuscular Module are shown in Table 5. The ma-
jority of intercorrelations were in the medium to large
range, supporting construct validity (P < 0.05).
Parent/child agreement
ICCs of the Chinese version scale are presented in
Table 6. Most inter-correlations of subscales between
child self-report and parent proxy-report were in the
moderate agreement range. The greatest overall agree-
ment was observed for the Total scale (0.51).
Discussion
The PedsQLTM 3.0 Neuromuscular Module is a
PedsQLTM disease-specific modules designed to measure
the neuromuscular specific HRQOL of pediatric pa-
tients. It has satisfactory psychometric properties for
both the child self-report and the parent proxy-report
and is appropriate for children in a broad age range. The
data described here support the feasibility, reliability,
and validity of the Chinese version of the PedsQLTM 3.0
Neuromuscular Module in children with DMD living in
mainland China. To our knowledge, it is also the first
time that the PedsQLTM 3.0 Neuromuscular Module was
tested on Chinese children with DMD.
There were minimal missing item responses in the
Chinese scale, indicating that children and their parents
were able to provide good-quality data regarding
pediatric HRQOL. However, our results show that there
were several items, i.e., “hard to gain or lose weight
when one wants to” and “do not have the equipment
one needs,” with missing responses. Notably, the per-
centage of missing values was primarily attributable to
2–7 year old children. The reason may be that younger
children had difficulty understand these questions, that
most of them could not gain or lose weight, or that they
did not require equipments because they were still able
to walk. Regardless, this finding is consistent with those
of the prior studies with other PedsQLTM disease-
specific modules [40] and indicates that some modifica-
tions for items of these subscales are necessary in tod-
dler and young child versions. In addition, the highest
ceiling effect was observed in the “About My/My Child’s
Neuromuscular Disease” subscale. It is understandable
in a mixed participant with different disease severity,
where the majority of children with DMD (66.07%)
could climb stairs which would be expected to influence
markedly their daily lives. There was also a notable floor
effect in the “Communication” subscale. It suggests that
children with DMD lack good communication; this
problem requires the joint efforts of the clinicians and
the community.
Internal consistency reliabilities of the Chinese version
exceeded the minimum alpha coefficient standard of
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report and parent proxy-report scales. These findings
are consistent with reliability estimates for the original
English version [11,12], indicating acceptable reliability
of the Chinese version scale. Although Cronbach’s alpha
represents the lower limit of reliability of a measurement
instrument and is a conservative estimate of actual reli-
ability [41], scales that did not meet the 0.70 standard
should only be used for descriptive analyses. Overall, re-
sponses to the Chinese version scale were in the good to
excellent agreement range across a 4–6 week period and
correlated significantly, supporting test-retest reliability
and demonstrating that the Chinese version scale is
stable over time.
In order to evaluate the item-subscale correlations
of the Chinese version scale, we analyzed Pearson
correlations between items and subscale scores. The
results of correlations between items and their hy-
pothesized subscales were high, but those between
items and other subscales were weak, indicating
good scaling success for child self-reports and parent
proxy-reports.
Construct validity was assessed with the Known-
Groups Method of comparing mobility groups (climb
stairs vs. non-climb). The a priori hypothesis that
“About My/My Child’s Neuromuscular Disease” subscale
would be significantly related to mobility was confirmed
for both child self-report and parent proxy-report. The
subscales of “Communication” and “About Our Family
Resources” showed unqualified discriminate abilities,
probably due to the relatively small sample size, and
both are recommended for further testing.
Construct validity was further tested by analyzing
inter-correlations among the Chinese version scale
Scores and the PedsQLTM 4.0 Generic Core Scales and
Summary Scores. Consistent with the conceptualization
of disease-specific symptoms as causal indicators of gen-
eric HRQOL, the majority of inter-correlations among
the Chinese version scale and the Generic Core Scales
were in the medium to large range, supporting construct
validity. Regarding the agreement between child self-
report and parent proxy-report of the Chinese version
scale, our data were mostly in the moderate agreement
range. This is consistent with both the adult and
pediatric literature, suggesting that information provided
by proxy-respondents is not equivalent to that reported
by patients [42,43]. Imperfect agreement between child
self-report and parent proxy-report has been consist-
ently documented in HRQOL measurements of children
with and without chronic illness [44,45], particularly for
less observable or internal symptoms.
This study has several limitations that should be con-
sidered when interpreting the results. In mainland
China, many children with DMD have refused orabandoned treatment for financial reasons, and HRQOL
information about these patients is lacking. All of the
subjects in this study were recruited in a large city
(Chongqing) in mainland China; determining whether
the scale can be generalized to other regions will require
further studies in other areas. Information on non-
participants’ and participants’ socioeconomic status was
not available and could affect our findings. The test-
retest data were obtained with an interval of around 4–
6 weeks, which was considered to be long enough to
make the children with DMD and their parents forget
their answers from the first test. However, a potential
limitation of the long interval was the possibility of the
occurrence of positive or negative events affecting the
participants. In addition, the small sample size did not
allow us to perform a factor analysis; correlation coeffi-
cients from factor analyses tend to be less reliable when
estimated from small sample sizes [46]. Future studies
with larger samples will allow factor analysis with this
population. Finally, we did not evaluate the responsive-
ness, which is used to detect HRQOL changes while a
patient’s health status changes over time and can be
regarded as additional evidence of instrument validity
[33]. Thus, further longitudinal studies are advised to as-
sess responsiveness.
Conclusions
This study is important because it is the first time
the PedsQLTM 3.0 Neuromuscular Module has been
applied in China. Our results provide reasonable evi-
dence that the Chinese version of the PedsQLTM 3.0
Neuromuscular Module has acceptable psychometric
properties. Given the potential differences between
patient and proxy reports, we recommend that the
pediatric patient self-report should be collected as
the primary patient-reported outcome, and the par-
ent proxy-report should be collected as a secondary
patient-reported outcome. Further longitudinal stud-
ies with larger samples should be carried out to con-
duct factor analysis and testing responsiveness of the
Chinese version scale, particularly in rural areas.Abbreviations
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